Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: Role of surgical manipulation

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2877-2884

  Galan, Maica ^a,b   Viñolas, Nuria ^a   Colomer, Dolors ^a   Soler, Gemma ^a   Muñoz, Montserrat ^a   Longarón, Raquel ^a   Joan Ventura, Pere ^a   Gascón, Pere ^a   Estapé, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

Breast cancer; Cytokeratin; Micrometastases; Peripheral blood; RT PCR

Indexed keywords

CYTOKERATIN 19; MESSENGER RNA;

ARTICLE; BLOOD ANALYSIS; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CELL TRANSPORT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METASTASIS; OCCULT CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; KERATINS; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM SEEDING; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, OPERATIVE;

EID: 0036765921     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Baum M: The curability of breast cancer. In: Breast Cancer Management (Stall BA, ed). London, Heinemann, 1977, pp 3-13.
2. Coombes RC, Powles TJ and Abbott M: Physical tests for distant metastases in patients with breast cancer. J R Soc Med 73: 617-623, 1980.
3. Osborne CK, Clark GM and Raudin PM: Adjuvant systemic therapy of primary breast cancer. In: Diseases of the Breast (Harris JR, Lippman ME, Morrow M and Hellman S, eds). Philadelphia, PA, Lippincott-Raven, 1996, pp 548-578.
4. Fisher B and Gebhardt MC: The evolution of breast cancer surgery: past, present, and future. Semin Oncol 5: 385, 1978.
5. Sugarbaker EV and Ketcham AS: Mechanisms and prevention of cancer dissemination: an overview. Semin Oncol 4: 19-32, 1977.
6. Weiss LA: Pathobiologic overview of metastasis. Semin Oncol 4: 5-17, 1977.
7. Cote RJ, Rosen PP, Lesser ML, Old LIJ and Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756, 1991.
8. Brown DC, Purushotham AD, Birnie GD and George WD: Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse-transcription and polymerase chain reaction. Surgery 117: 96-101, 1995.
9. Goldblatt SA and Nadel EM: Cancer cells in the circulating blood: a critical review. Acta Cytol 9: 6-20, 1965.
10. Leather AJM, Gallegos NC, Kocjan G, Savage F, Smales CS, Hu W, Boulos PB, Northover JMA and Phillips RKS: Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 80: 777-780, 1993.
11. Saiki R, Scharf S, Faloona, Mullis KB, Horn GT, Erlich HA and Arnheim N: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350-1354, 1985.
12. Mattano LA (jr), Moss TJ and Emerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52: 4701-4705, 1992.
13. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG and Gomella LG: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110-6112, 1992.
14. Oefelein MG, Kaul K, Herz B, Blum MD, Holland JM, Keeler TC, Cook WA and Ignatoff JM: Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J Urol 155: 238-242, 1996.
15. Battayani Z, Grob JJ, Xerri L, Noe C, Zarour H, Houvaeneghel G, Delpero JR, Birmbaum D, Hassoun J and Bonerandi JJ: Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 131: 443-447, 1995.
16. Mellado B, Colomer D, Castel T, Muñoz M, Carballo E, Galán M, Mascaró JM, Vives-Corrons JLI, Grau JJ and Estapé J: Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 4: 2091-2097, 1996.
17. Palmieri G, Strazzullo M, Ascierto PA, Satriano SMR, Daponte A and Castello G: Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. J Clin Oncol 17: 304-311, 1999.
18. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K and Akiyoshi T: Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease. Int J Cancer 68: 739-743, 1996.
19. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K and Akiyoshi T: Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 16: 128-132, 1998.
20. Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C and Doeberitz MVK: Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Cl Cancer Res 4: 343-348, 1998.
21. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482, 1994.
22. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE and Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14: 868-876, 1996.
23. Vannucchi AM, Bosi A, Glinz S, Pacini P, Linari S, Saccardi R, Alterini R, Rigacci R, Guidi S, Lombardini L, Longo G, Mariani MP and Rossi-Ferrini P: Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. Br J Haematol 103: 610-617, 1998.
24. Hardingham JE, Kotasek D, Sage RE, Eaton MC, Pascoe VH and Dobrovic A: Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Molecular Medicine 1: 789-794, 1995.
25. Schatten WE: An experimental study of postoperative tumor metastases. I. Growth of pulmonary metastases following total removal of primary leg tumor. Cancer 11: 455-459, 1958.
26. Ketcham AS, Wexler H and Mantel N: The effect of removal of a "primary" tumor on the development of spontaneous metastases. I. Development of a standardized experimental technique. Cancer Res 19: 940-944, 1959.
27. Ketcham AS, Kinsey DL, Wexler H and Mantel N: The development of spontaneous metastases after the removal of a "primary" tumor. II. Standardization protocol of 5 animal tumors. Cancer 14: 875-882, 1961.
28. Simpson-Herren L, Sanford AH and Holmquist JP: Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 60: 1749-1760, 1976.
29. Gunduz N, Fisher B and Saffer EA: Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39: 3861-3865, 1979.
30. Fisher B, Gunduz N and Saffer E: Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 43: 1488-1492, 1983.
31. Harris DT and Mastrangelo MJ: Theory and application of early systemic therapy. Seminars in Oncology 18: 493-503, 1991.
32. Marie P and Clunet J: Fréquence des métastase viscérales chez les souris cancéreuses après ablation chirurgicale de leur tumeur. Bull Assoc Franç p l'étude du cancer 3: 19-23, 1910.
33. Fisher B, Gunduz N and Coyle J: Presence of growth-stimulating factor in serum following primary tumor removal. Cancer Res 49: 1996-2001, 1989.
34. Tyzzer EE: Factors in the production and growth of tumor metastasis. J Med Res 28: 309-331, 1913.
35. Romsdahl MD, Chu EW, Hume R and Smith RR: The time of metastasis and release of circulating tumor cells as determined in an experimental system. Cancer 14: 883-888, 1961.
36. Romsdahl MM, McGrath RG, Hoppe E and McGrew EA: Experimental model for the study of tumor cells in the blood, Acta Cytol 9: 151-155, 1965.
37. Liotta LA, Kleinerman J and Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessel and pulmonary metastasis following tumor implantation. Cancer Res 34: 997-1004, 1974.
38. Nishizaki T, Matsumata T, Kanematsu, Yasunaga C and Sugimachi KT: Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res 49: 92-97, 1990.
39. Boyum A: Separation of leukocytes from blood and bone marrow. Scand J Clin Invest 21: 51-55, 1968.
40. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
41. Bader BL, Jahn L and Franke WW: Low level expression of cytokeratin 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 47: 300-319, 1988.
42. Savtchenko ES, Schiff TA and Jiang CK: Embryonic expression of the human 40-kD keratin: Evidence from a processed pseudogene sequence. Am J Hum Genet 43: 630-637, 1988.
43. Ruud P, Fodstad O and Hovig E: Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 80: 119-125, 1999.
44. Cross NC, Hugues TP and Feng L: Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 84: 67-74, 1993.
45. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H and Akiyoshi T: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
46. Luppi M, Morselli M, Bandieri E, Federico M, Marasca R, Barozzi P, Ferrari MG, Savarino M, Frassoldati A and Torelli G: Sensitive detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7: 619-624, 1996.
47. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD and Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-2990, 1994.
48. Moscinski LC, Trudeau WL, Fields KK and Elfenbein GJ: High-sensitivity detection of minimal residual breast carcinoma using polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 5: 173-180, 1996.
49. Aerts J, Wynendaele W and Paridaens R: A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann Oncol 12: 39-46, 2001.
50. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R and Hoon DSB: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-2640, 1998.
51. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF and Rosai J: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13: 1195-1200, 1995.
52. Glaves D, Huben R and Weiss L: Haematogenous dissemination of cells from human renal adenocarcinoma. Br J Cancer 54: 32-35, 1988.
53. Mansi NL, Berger U, Easton D, McDonnell T, Redding H, Gazet JC, McKinna A, Powles TJ and Coombes C: Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093-1096, 1987.
54. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC and Reville AM: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6, 1988.
55. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S and Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10: 1534-1539, 1992.
56. Fidler IJ: The biology of human cancer metastasis. Acta Oncol 30: 669-675, 1991.
57. Liotta LA and Steeler-Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51 (suppl): S5054-S5059, 1991.
58. Braun S, Pantel K, Muller P, Jani W, Hepp F, Kentenich CRM, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G and Schlimok G: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342: 525-533, 2000.
59. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A and Atzpodien J: Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Nat Cancer Inst 88: 590-594, 1996.
60. Ghossein RA, Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S, Houghton A and Rosai J: Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4: 419-428, 1998.
61. Roberts S, Watne A, McGrath R, McGrew E and Cole WH: Technique and results of isolation of cancer cells from the circulating blood. A.M.A. Arch Surg 76: 334-346, 1958.